A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B
NCT07200193
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
66
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Hepaititis B
Interventions
GENETIC:
CRMA-1001
Sponsor
nChroma Bio